Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Katherine Stueland net worth and biography

Katherine Stueland Biography and Net Worth

Insider of Invitae

Katherine is passionate about how genetic information can help everyone make more informed healthcare decisions through testing and the power of a network that connects patients, clinicians, researchers, and patient communities to better inform what a patient can do with their diagnosis. With a relentless focus on opening up access for patients, she leads Invitae’s global commercial teams, including sales, international, biopharma partnerships, the direct ordering channel for patients, marketing, customer service, new market development, and communications/investor relations. Katherine cares deeply about the importance of broadening research to diverse patient populations to advance science and patient care for everyone. She previously led Invitae’s communications and investor relations team. Prior to joining Invitae, Katherine worked with management teams of biopharma companies, including serving as vice president of communications and investor relations at Dendreon, the first company to bring an immuno-oncology product to market. Katherine holds a B.S. in English Language and Literature from Miami University in Ohio.

What is Katherine Stueland's net worth?: The estimated net worth of Katherine Stueland is at least $226.77 as of March 18th, 2024. Ms. Stueland owns 66,698 shares of Invitae stock worth more than $227 as of April 19th. This net worth approximation does not reflect any other investments that Ms. Stueland may own. Learn More about Katherine Stueland's net worth.
How do I contact Katherine Stueland?: The corporate mailing address for Ms. Stueland and other Invitae executives is 1400 16th Street, SAN FRANCISCO CA, 94103. Invitae can also be reached via phone at (628) 213-3369 and via email at [email protected]. Learn More on Katherine Stueland's contact information.
Has Katherine Stueland been buying or selling shares of Invitae?: Katherine Stueland has not been actively trading shares of Invitae in the last ninety days. Most recently, Katherine Stueland sold 20,340 shares of the business's stock in a transaction on Monday, June 14th. The shares were sold at an average price of $31.60, for a transaction totalling $642,744.00. Learn More on Katherine Stueland's trading history.
Who are Invitae's active insiders?: Invitae's insider roster includes Thomas Brida (General Counsel), Sean George (CEO), Shelly Guyer (CFO), Robert Nussbaum (Insider), Katherine Stueland (Insider), and Robert Werner (CAO). Learn More on Invitae's active insiders.
Are insiders buying or selling shares of Invitae?: During the last year, insiders at the medical research company sold shares 5 times. They sold a total of 144,005 shares worth more than $208,408.56. The most recent insider tranaction occured on June, 13th when insider Robert L Nussbaum sold 7,086 shares worth more than $9,778.68. Insiders at Invitae own 0.7% of the company. Learn More about insider trades at Invitae.
Information on this page was last updated on 6/13/2023.

Katherine Stueland Insider Trading History at Invitae

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/14/2021	Sell	20,340	$31.60	$642,744.00
4/14/2021	Sell	19,893	$39.87	$793,133.91
3/15/2021	Sell	12,443	$42.90	$533,804.70
2/25/2021	Sell	5,000	$39.96	$199,800.00
1/13/2021	Sell	4,199	$51.82	$217,592.18
12/14/2020	Sell	34,300	$58.43	$2,004,149.00
11/13/2020	Sell	1,000	$48.00	$48,000.00
10/13/2020	Sell	1,000	$51.36	$51,360.00
9/15/2020	Sell	1,000	$35.51	$35,510.00
8/19/2020	Sell	21,345	$32.10	$685,174.50
8/12/2020	Sell	1,000	$29.31	$29,310.00
7/14/2020	Sell	1,000	$32.50	$32,500.00
6/12/2020	Sell	1,000	$16.34	$16,340.00
5/13/2020	Sell	1,000	$17.56	$17,560.00
4/13/2020	Sell	1,000	$12.80	$12,800.00
3/16/2020	Sell	10,684	$11.79	$125,964.36	224,786
3/13/2020	Sell	1,000	$11.64	$11,640.00	224,786
2/27/2020	Sell	1,000	$20.44	$20,440.00
1/14/2020	Sell	1,000	$18.14	$18,140.00
12/13/2019	Sell	1,000	$17.08	$17,080.00
11/14/2019	Sell	3,788	$17.46	$66,138.48
9/17/2019	Sell	3,788	$21.40	$81,063.20
8/16/2019	Sell	3,789	$24.98	$94,649.22
7/15/2019	Sell	3,789	$22.49	$85,214.61
6/13/2019	Sell	3,789	$19.36	$73,355.04
5/15/2019	Sell	1,000	$18.36	$18,360.00
4/16/2019	Sell	1,000	$25.23	$25,230.00
3/15/2019	Sell	1,000	$23.49	$23,490.00
2/27/2019	Sell	1,000	$19.61	$19,610.00
1/15/2019	Sell	1,000	$13.59	$13,590.00
12/17/2018	Sell	1,000	$11.44	$11,440.00
9/9/2018	Sell	595	$13.62	$8,103.90	191,963
9/12/2017	Sell	612	$9.40	$5,752.80	58,570

Katherine Stueland Buying and Selling Activity at Invitae

Invitae Company Overview

Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

Today's Range

Now: $0.00

$0.00

$0.01

50 Day Range

MA: $0.01

$0.00

$0.04

2 Week Range

Now: $0.00

$0.02

Volume

680,460 shs

Average Volume

23,716,614 shs

Market Capitalization

$907,834.00

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.59

Tiny Biotech Stock Wins $75 Billion Patent

From Behind the Markets | Ad

Find out more here >>>